162 related articles for article (PubMed ID: 4990004)
21. Etoposide with/without G-CSF with busulfan and cyclophosphamide as conditioning for bone marrow transplantation. The BMT Team.
Kanda Y; Akiyama H; Tanikawa S; Sakamaki H; Sasaki T; Takamoto S; Onozawa Y
Am J Hematol; 1996 Apr; 51(4):265-8. PubMed ID: 8602625
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells.
Neelis KJ; Dubbelman YD; Qingliang L; Thomas GR; Eaton DL; Wagemaker G
Exp Hematol; 1997 Sep; 25(10):1084-93. PubMed ID: 9293906
[TBL] [Abstract][Full Text] [Related]
23. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
[TBL] [Abstract][Full Text] [Related]
24. [Myelotoxicity due to cancer chemotherapy with special reference to autologous bone marrow transplantation].
Nakamura S
Gan No Rinsho; 1984 Jul; 30(9 Suppl):1195-202. PubMed ID: 6381786
[TBL] [Abstract][Full Text] [Related]
25. [Isogeneic bone marrow transplantation in rats previously treated with cyclophosphamide (preliminary report)].
Hernández P; Carmena A; Callejas J
Rev Clin Esp; 1972 Mar; 124(6):587-90. PubMed ID: 4602405
[No Abstract] [Full Text] [Related]
26. [Cytopenias with dyshematopoiesis after hypoglycemic sulfamide treatment. Apropos of 3 cases].
Perlemuter L; Hazard J; Dreyfus B; Farge B
Sem Hop; 1971 Dec; 47(53):3079-85. PubMed ID: 4336339
[No Abstract] [Full Text] [Related]
27. [On clinical use of high single doses of sarcolysine and exdoxan (cyclophosphan)].
Garin AM; Astrakhan VI; Bychkov MB; Larionov LF; Perevodchikova NI
Vopr Onkol; 1965; 11(10):3-9. PubMed ID: 5333877
[No Abstract] [Full Text] [Related]
28. Accelerated regeneration of transplanted hematopoietic stem cells in irradiated mice pretreated with cyclophosphamide.
Gregory SA; Fried W; Knospe WH; Trobaugh FE
Blood; 1971 Feb; 37(2):196-203. PubMed ID: 4927143
[No Abstract] [Full Text] [Related]
29. Symposium on bone marrow transplantation: experimental aspects in canines.
Thomas ED; Storb R; Epstein RB; Rudolph RH
Transplant Proc; 1969 Mar; 1(1):31-3. PubMed ID: 5002661
[No Abstract] [Full Text] [Related]
30. Effects of cyclophosphamide on the blood and bone marrow of the guinea-pig.
Kaul M; Hudson G
J Anat; 1969 Jan; 104(Pt 1):190. PubMed ID: 5779563
[No Abstract] [Full Text] [Related]
31. [Results of very high cyclophosphamide dosage in 42 patients with solid and lymphoreticular tumors].
Schubert JC; Ischer M; Hilbert L
Dtsch Med Wochenschr; 1969 Dec; 94(50):2583-8 passim. PubMed ID: 4187888
[No Abstract] [Full Text] [Related]
32. Prolonged isolated thrombocytopenia after hematopoietic stem cell transplantation: morphologic correlation.
Bielski M; Yomtovian R; Lazarus HM; Rosenthal N
Bone Marrow Transplant; 1998 Dec; 22(11):1071-6. PubMed ID: 9877269
[TBL] [Abstract][Full Text] [Related]
33. Changes in marrow myelopoietic and lymphoid cell counts after repeated cyclophosphamide administration in the rat.
Berger J
Haematologia (Budap); 1981 Dec; 14(4):407-16. PubMed ID: 7344975
[TBL] [Abstract][Full Text] [Related]
34. [Medullotherapy in hematopoietic depression].
Sherman SI; Shabalin VN; Abdulkadyrov KM
Vopr Onkol; 1980; 26(2):3-7. PubMed ID: 6767309
[TBL] [Abstract][Full Text] [Related]
35. Amelioration of cyclophosphamide-induced myelosuppression during treatment to rats with breast cancer through low-intensity pulsed ultrasound.
Wang W; Luo D; Chen J; Chen J; Xia Y; Chen W; Wang Y
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32936241
[TBL] [Abstract][Full Text] [Related]
36. Successful autologous bone marrow transplant without the use of blood product support.
Ballen KK; Ford PA; Waitkus H; Emmons RV; Levy W; Doyle P; Stewart FM; Quesenberry PJ; Becker PS
Bone Marrow Transplant; 2000 Jul; 26(2):227-9. PubMed ID: 10918437
[TBL] [Abstract][Full Text] [Related]
37. [Course of hematotoxic cyclophosphamide effects in the rat].
Werner W; Haller M; Höpfner V; Küchler J; Ziervogel J
Exp Pathol (Jena); 1971; 5(1):123-7. PubMed ID: 5098036
[No Abstract] [Full Text] [Related]
38. [BEHAVIOR OF THE BLOOD OF SUBJECTS TREATED WITH CYCLOPHOSPHAMIDE IN LARGE DOSES AND WITH AUTOGRAFTS OF BONE MARROW].
CAPRIO G; PELLEGRIS G; DIPIETRO S
Haematologica; 1963; 48():349-60. PubMed ID: 14124968
[No Abstract] [Full Text] [Related]
39. Improvement of mitomycin C- and cyclophosphamide-induced thrombocytopenia and leucocytopenia by prior treatment with deoxyspergualin in dogs.
Nemoto K; Ogino M; Sugawara Y; Abe F; Ito J; Takeuchi T
Br J Haematol; 1994 Jul; 87(3):572-5. PubMed ID: 7993798
[TBL] [Abstract][Full Text] [Related]
40. Autologous transplant for chronic myelogenous leukemia using marrow treated ex vivo with mafosfamide.
Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Cottafavi L; Dotti GP; Rizzoli V
Bone Marrow Transplant; 1994 Sep; 14(3):425-32. PubMed ID: 7994267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
